This user has not filled out their profile yet.

How will Trump's FDA approach stem cells?

Posted 5 months.

2 Comments

  • Alta Charo - 5 months ago

    The option that seemed to be missing was related to funding -- will the research using embryonic stem cells receive the same, less or more funding. And same question regarding stem cells taken from fetal tissue.

  • Gregory Nathan - 5 months ago

    "Weaker" is a poor choice of words. Laissez faire and restraint is a sign of STRENGTH. The choices in the survey should be a spectrum between "Looser oversight --> Stricter oversight", even better... "Regulatory gridlock --> Doctor-Patient freedom"
    I think the FDA will get this right.

Leave a Comment

0/4000 chars


Submit Comment